Exhibit 99.1
Herbalife Ltd. Announces Record Third Quarter, Raises FY’10 Guidance and Provides Initial FY’11 Guidance
LOS ANGELES--(BUSINESS WIRE)--November 1, 2010--Herbalife Ltd. (NYSE:HLF) today reported that third quarter net sales increased 14.7 percent to $688.4 million. The net sales reflect volume point growth of 13.5 percent and an increase in Average Active Sales Leaders of 11.8 percent, both compared to the third quarter of 2009. Excluding the impact from adjusting items in the third quarter1, net income was $72.5 million, or $1.17 per diluted share, representing increases of 34.1 percent and 37.6 percent respectively compared to $54.1 million or $0.85 per diluted share in the third quarter of 2009. These 2010 third quarter adjusted results exclude an income tax benefit of $3.2 million, or $0.05 benefit to diluted EPS resulting from an international income tax audit settlement.
For the quarter ended September 30, 2010, the company reported net income of $75.7 million or $1.22 per diluted share compared to $57.9 million and $0.91 per diluted share in the third quarter of 2009, primarily reflecting the benefit of higher net sales, improved margins and a lower effective tax rate, partially offset by the impact of foreign currency fluctuations.
For the quarter ended September 30, 2010, the company generated cash flows from operations of $97.3 million, paid dividends of $14.9 million, invested $18.3 million in capital expenditures and repurchased $24.9 million in common shares as part of the company’s $1 billion share repurchase authorization program. The company’s net debt balance at the end of the third quarter was $15.6 million, reflecting an improvement of $83.9 million from December 31, 2009.
“Our distributors are driving momentum around the world by attracting and retaining long-term customers for our nutrition products, which builds successful and sustainable businesses,” said Chairman and Chief Executive Officer Michael O. Johnson. “We are pleased by the broad and ongoing strength of our results this quarter, with all six of our regions experiencing volume growth and year-over-year improvement in active sales leaders.”
During the third quarter the company hosted approximately 35,600 distributors at Extravaganzas in Ukraine, Italy, Sweden and Mexico.
Third Quarter 2010 Regional Key Metrics2, 3
Regional and Emerging/Established Market Breakdowns |
|||||||||
Regional |
3Q'10 Volume Points
(Mil) |
% Chg
(Y/Y) |
3Q'10 Avg Active Sales Leaders |
3Q'10
Average Active Sales Leaders % Chg (Y/Y) |
|||||
North America | 225.4 | 8.6 | % | 51,095 | 13.7 | % | |||
Asia Pacific | 191.8 | 29.4 | % | 37,291 | 26.7 | % | |||
EMEA | 114.3 | 4.5 | % | 33,625 | 3.0 | % | |||
Mexico | 146.2 | 15.7 | % | 39,521 | 11.4 | % | |||
South & Central America | 107.3 | 5.0 | % | 29,548 | 3.9 | % | |||
China | 39.4 | 22.0 | % | 7,548 | 19.7 | % | |||
Worldwide Total | 824.4 | 13.5 | % | 191,072 | 11.8 | % | |||
3Q'10 Volume Points
(Mil) |
% Chg
(Y/Y) |
3Q'10 Avg Active Sales Leaders |
3Q'10
Average Active Sales Leaders % Chg (Y/Y) |
||||||
Emerging Markets |
431.6 |
14.8 | % | 107,271 | 11.6 | % | |||
Established Markets | 392.8 | 12.2 | % | 91,238 | 12.5 | % |
Updated 2010 Guidance
Based on current business trends, the company’s fourth quarter and fiscal 2010 guidance are provided below.
Fourth Quarter 2010 - The company’s fourth quarter 2010 diluted earnings per share guidance range is $1.07 to $1.11 on volume point growth of 11.0 percent to 13.0 percent and net sales growth of 13.0 percent to 15.0 percent compared to the same period in 2009 and an effective tax rate range of 30.0 percent to 31.0 percent. The company’s fourth quarter 2010 capital expenditures are expected to be in the range of $23.0 million to $33.0 million.
Fiscal 2010 - Excluding the impact from adjusting item4 the company’s new full-year diluted earnings per share guidance is $4.54 to $4.58 on volume point growth of 12.5 percent to 13.5 percent and a net sales increase of 16.5 percent to 17.0 percent compared to 2009, respectively, along with an effective tax rate range of 28.0 percent to 29.0 percent. Full-year 2010 capital expenditures are expected to be in the range of $65.0 million to $75.0 million.
2011 Guidance
Based on current business trends, FX rates as of the end of September, 2010, and the company’s outlook for future performance, the company is initiating guidance for 2011 with a diluted earnings per share guidance range of $5.00 to $5.25 on a volume point growth of 8.0 to 10.0 percent and a net sales growth of 11.0 percent to 13.0 percent compared to the same period in 2010 and an effective tax rate range of 29.0 percent to 30.0 percent. The company’s guidance for capital spending in 2011 is in the range of $80 million to $90 million.
Third Quarter Earnings Conference Call
Herbalife's senior management team will host an investor conference call Tuesday, November 2, 2010 at 8 a.m. ET (5 a.m. PT) to discuss its recent financial results and provide an update on current business trends preceding its annual analyst day to discuss its recent financial results and provide an update on current business trends.
The dial-in number for this presentation for domestic callers is (866) 903-5314 and (706) 634-5671 for international callers (conference ID 82534647). Live audio of the presentation will be simultaneously webcast in the investor relations section of the company's website at http://ir.herbalife.com.
An audio replay will be available following the completion of the presentation in MP3 format or by dialing (800) 642-1687 (domestic callers) or (706) 645-9291 (international callers) and entering Encore ID 66642385. The webcast of the presentation will be archived and available on Herbalife's website.
About Herbalife Ltd.
Herbalife Ltd. (NYSE:HLF) is a global network marketing company that sells weight-management, nutrition, and personal care products intended to support a healthy lifestyle. Herbalife products are sold in 73 countries through a network of approximately 2.0 million independent distributors. The company supports the Herbalife Family Foundation and its Casa Herbalife program to help bring good nutrition to children. Herbalife’s Web site contains a significant amount of information about Herbalife, including financial and other information for investors at http://ir.herbalife.com. The company encourages investors to visit its Web site from time to time, as information is updated and new information is posted.
Disclosure Regarding Forward-Looking Statements
FORWARD-LOOKING STATEMENTS
This document contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Forward-looking statements may include the words “may,” “will,” “estimate,” “intend,” “continue,” “believe,” “expect” or “anticipate” and any other similar words.
Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, such as those disclosed or incorporated by reference in our filings with the Securities and Exchange Commission. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in our forward-looking statements include, among others, the following:
• any collateral impact resulting from the ongoing worldwide financial “crisis,” including the availability of liquidity to us, our customers and our suppliers or the willingness of our customers to purchase products in a recessionary economic environment
• our relationship with, and our ability to influence the actions of, our distributors;
• improper action by our employees or distributors in violation of applicable law;
• adverse publicity associated with our products or network marketing organization;
• changing consumer preferences and demands;
• our reliance upon, or the loss or departure of any member of, our senior management team which could negatively impact our distributor relations and operating results;
• the competitive nature of our business;
• regulatory matters governing our products, including potential governmental or regulatory actions concerning the safety or efficacy of our products, and network marketing program including the direct selling market in which we operate;
• third party legal challenges to our network marketing program;
• risks associated with operating internationally and the effect of economic factors, including foreign exchange, inflation, pricing and currency devaluation risks, especially in countries such as Venezuela;
• uncertainties relating to the application of transfer pricing, duties, value added taxes, and other tax regulations, and changes thereto;
• uncertainties relating to interpretation and enforcement of recently enacted legislation in China governing direct selling;
• our inability to obtain the necessary licenses to expand our direct selling business in China;
• adverse changes in the Chinese economy, Chinese legal system or Chinese governmental policies
• our dependence on increased penetration of existing markets;
• contractual limitations on our ability to expand our business;
• our reliance on our information technology infrastructure and outside manufacturers;
• the sufficiency of trademarks and other intellectual property rights;
• product concentration;
• changes in tax laws, treaties or regulations, or their interpretation;
• taxation relating to our distributors;
• product liability claims; and
• whether we will purchase any of our shares in the open markets or otherwise.
We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.
1 See Schedule B – “Reconciliation of Non-GAAP Financial Measures” for more detail.
2 “Emerging” markets are being defined as those countries which the World Bank categorizes as having “low” or “medium” GDP per capita, while “Established” are those that the World Bank considers to have “high” GDP per capita.
3 Supplemental tables that include additional business metrics can be found at http://www.ir.herbalife.com
4 FY’10 guidance excludes the impact from the first quarter implementation of highly inflationary accounting in Venezuela and a third quarter tax benefit from international income tax audit settlement.
RESULTS OF OPERATIONS:
Herbalife Ltd. | |||||||||||||
Consolidated Statements of Income | |||||||||||||
(In thousands, except per share data) | |||||||||||||
(Unaudited) | |||||||||||||
Quarter Ended | Nine Months Ended | ||||||||||||
9/30/2010 | 9/30/2009 | 9/30/2010 | 9/30/2009 | ||||||||||
North America | $ | 155,532 | $ | 140,829 | $ | 473,228 | $ | 402,294 | |||||
Mexico | 83,498 | 68,290 | 236,265 | 193,881 | |||||||||
South and Central America | 95,030 | 93,035 | 269,156 | 253,702 | |||||||||
EMEA | 121,221 | 123,334 | 387,598 | 373,222 | |||||||||
Asia Pacific | 181,555 | 129,240 | 494,418 | 357,723 | |||||||||
China | 51,595 | 45,490 | 135,205 | 112,884 | |||||||||
Worldwide net sales | 688,431 | 600,218 | 1,995,870 | 1,693,706 | |||||||||
Cost of Sales | 133,265 | 131,777 | 410,298 | (1 | ) | 356,619 | |||||||
Gross Profit | 555,166 | 468,441 | 1,585,572 | 1,337,087 | |||||||||
Royalty Overrides | 224,061 | 194,639 | 656,160 | 556,921 | |||||||||
SGA | 230,150 | 195,968 | 648,143 | (1 | ) | 568,220 | |||||||
Operating Income | 100,955 | 77,834 | 281,269 | 211,946 | |||||||||
Interest Expense - net | 2,192 | 1,037 | 6,291 | 4,087 | |||||||||
Income before income taxes | 98,763 | 76,797 | 274,978 | 207,859 | |||||||||
Income Taxes | 23,024 | 18,902 | 65,435 | (1 | ) | 60,169 | |||||||
Net Income | $ | 75,739 | $ | 57,895 | $ | 209,543 | $ | 147,690 | |||||
Basic Shares | 59,221 | 61,234 | 59,643 | 61,467 | |||||||||
Diluted Shares | 61,946 | 63,397 | 62,250 | 63,049 | |||||||||
Basic EPS | $ | 1.28 | $ | 0.95 | $ | 3.51 | $ | 2.40 | |||||
Diluted EPS | $ | 1.22 | $ | 0.91 | $ | 3.37 | $ | 2.34 | |||||
Dividends declared per share | $ | 0.25 | $ | 0.20 | $ | 0.65 | $ | 0.60 | |||||
1 Includes impact of items related to adoption of highly-inflationary accounting in Venezuela that are further discussed in Schedule B – "Reconciliation of Non-GAAP Financial Measures”
|
|||||||||||||
Herbalife Ltd. | |||||||
Consolidated Balance Sheets | |||||||
(In thousands) | |||||||
(Unaudited) | |||||||
Sep 30, | Dec 31, | ||||||
2010 | 2009 | ||||||
ASSETS | |||||||
Current Assets: | |||||||
Cash & cash equivalents | $ | 193,490 | $ | 150,801 | |||
Receivables, net | 91,394 | 76,958 | |||||
Inventories | 183,144 | 145,962 | |||||
Prepaid expenses and other current assets | 97,716 | 101,181 | |||||
Deferred income taxes | 56,237 | 38,600 | |||||
Total Current Assets | 621,981 | 513,502 | |||||
Property and equipment, net | 169,308 | 178,009 | |||||
Deferred compensation plan assets | 17,781 | 17,410 | |||||
Deferred financing cost, net | 1,124 | 1,498 | |||||
Other assets | 24,271 | 21,306 | |||||
Marketing related intangibles and other intangible assets, net | 310,992 | 311,782 | |||||
Goodwill | 102,899 | 102,543 | |||||
Total Assets | $ | 1,248,356 | $ | 1,146,050 | |||
LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||
Current Liabilities: | |||||||
Accounts payable | $ | 50,068 | $ | 37,330 | |||
Royalty Overrides | 149,215 | 144,689 | |||||
Accrued compensation | 67,318 | 65,043 | |||||
Accrued expenses | 122,453 | 107,943 | |||||
Current portion of long term debt | 3,232 | 12,402 | |||||
Advance sales deposits | 54,637 | 22,261 | |||||
Income taxes payable | 16,602 | 40,298 | |||||
Total Current Liabilities | 463,525 | 429,966 | |||||
Non-current liabilities | |||||||
Long-term debt, net of current portion | 205,894 | 237,931 | |||||
Deferred compensation | 18,827 | 16,629 | |||||
Deferred income taxes | 76,045 | 77,613 | |||||
Other non-current liabilities | 23,476 | 24,600 | |||||
Total Liabilities | 787,767 | 786,739 | |||||
Contingencies | |||||||
Shareholders' equity: | |||||||
Common shares | 118 | 120 | |||||
Additional paid in capital | 247,189 | 222,882 | |||||
Accumulated other comprehensive loss | (24,636 | ) | (23,396 | ) | |||
Retained earnings | 237,918 | 159,705 | |||||
Total Shareholders' Equity | 460,589 | 359,311 | |||||
Total Liabilities and Shareholders' Equity | $ | 1,248,356 | $ | 1,146,050 | |||
Herbalife Ltd. | ||||||||
Consolidated Statements of Cash Flows | ||||||||
(In thousands) | ||||||||
(Unaudited) | ||||||||
Nine Months Ended | ||||||||
9/30/2010 | 9/30/2009 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
Net income | $ | 209,543 | $ | 147,690 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 51,755 | 45,646 | ||||||
(Excess) Deficiency in tax benefits from share-based payment arrangements | (9,959 | ) | 759 | |||||
Share-based compensation expenses | 16,870 | 15,100 | ||||||
Amortization of discount and deferred financing costs | 374 | 367 | ||||||
Deferred income taxes | (16,989 | ) | (3,098 | ) | ||||
Unrealized foreign exchange transaction (gain) loss | (7,536 | ) | 6,763 | |||||
Foreign exchange loss from adoption of highly inflationary accounting in Venezuela | 15,131 | — | ||||||
Other | 2,911 | 233 | ||||||
Changes in operating assets and liabilities: | ||||||||
Receivables | (13,965 | ) | (9,265 | ) | ||||
Inventories | (32,921 | ) | 10,451 | |||||
Prepaid expenses and other current assets | 5,744 | (5,724 | ) | |||||
Other assets | (2,328 | ) | 354 | |||||
Accounts payable | 12,852 | (4,851 | ) | |||||
Royalty overrides | 3,601 | 9,525 | ||||||
Accrued expenses and accrued compensation | 11,622 | 5,870 | ||||||
Advance sales deposits | 32,399 | 21,011 | ||||||
Income taxes payable | (13,568 | ) | (15,529 | ) | ||||
Deferred compensation plan liability | 2,198 | 1,992 | ||||||
NET CASH PROVIDED BY OPERATING ACTIVITIES | 267,734 | 227,294 | ||||||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
Purchases of property | (42,199 | ) | (41,776 | ) | ||||
Proceeds from sale of property | 64 | 93 | ||||||
Acquisition of business | — | (10,000 | ) | |||||
Deferred compensation plan assets | (371 | ) | (1,321 | ) | ||||
NET CASH USED IN INVESTING ACTIVITIES | (42,506 | ) | (53,004 | ) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
Dividends paid | (38,934 | ) | (36,727 | ) | ||||
Borrowings from long-term debt | 338,000 | 138,974 | ||||||
Principal payments on long-term debt | (379,465 | ) | (180,540 | ) | ||||
Share repurchases | (106,163 | ) | (33,630 | ) | ||||
Excess (Deficiency in) tax benefits from share-based payment arrangements | 9,959 | (759 | ) | |||||
Proceeds from exercise of stock options and sale of stock under employee stock purchase plan | 11,521 | 2,209 | ||||||
NET CASH USED IN FINANCING ACTIVITIES | (165,082 | ) | (110,473 | ) | ||||
EFFECT OF EXCHANGE RATE CHANGES ON CASH | (17,457 | ) | 737 | |||||
NET CHANGE IN CASH AND CASH EQUIVALENTS | $ | 42,689 | $ | 64,554 | ||||
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | 150,801 | 150,847 | ||||||
CASH AND CASH EQUIVALENTS, END OF PERIOD | $ | 193,490 | $ | 215,401 | ||||
CASH PAID DURING THE PERIOD | ||||||||
Interest paid | $ | 7,195 | $ | 8,443 | ||||
Income taxes paid, net | $ | 84,120 | $ | 77,397 | ||||
NON CASH ACTIVITIES | ||||||||
Assets acquired under capital leases and other long-term debt | $ | 524 | $ | 339 | ||||
Herbalife Ltd |
||||||
Volume Points by Region |
||||||
(Unaudited, In thousands) |
||||||
Three Months Ended September 30, | ||||||
2010 | 2009 | % Change | ||||
North America | 225,379 | 207,612 | 8.6 | % | ||
Asia Pacific (excluding China) | 191,824 | 148,184 | 29.4 | % | ||
EMEA | 114,274 | 109,429 | 4.4 | % | ||
Mexico | 146,236 | 126,375 | 15.7 | % | ||
South & Central America | 107,286 | 102,166 | 5.0 | % | ||
China | 39,364 | 32,270 | 22.0 | % | ||
Worldwide | 824,363 | 726,036 | 13.5 | % | ||
SUPPLEMENTAL INFORMATION
SCHEDULE A: FINANCIAL GUIDANCE
2010 Guidance | |||||||||||||||||||||
For the Three Months and Twelve Months Ending December 31, 2010 | |||||||||||||||||||||
Three Months Ending | Twelve Months Ending | ||||||||||||||||||||
December 31, 2010 | December 31, 2010 | ||||||||||||||||||||
Low | High | Low | High | ||||||||||||||||||
Volume point growth vs 2009 | 11.0 | % | 13.0 | % |
12.5 |
% |
13.5 |
% | |||||||||||||
Net sales growth vs 2009 | 13.0 | % | 15.0 | % |
16.5 |
% |
17.0 |
% | |||||||||||||
EPS 1 | $ |
1.07 |
$ |
1.11 |
$ |
4.54 |
$ |
4.58 |
|||||||||||||
Cap Ex ($ millions) | $ | 23.0 | $ | 33.0 | $ | 65.0 | $ | 75.0 | |||||||||||||
Effective Tax Rate 1 | 30.0 | % | 31.0 | % | 28.0 | % | 29.0 | % | |||||||||||||
2011 Guidance | ||||||
For the Twelve Months Ending December 31, 2011 | ||||||
Twelve Months Ending | ||||||
December 31, 2011 | ||||||
Low |
High |
|||||
Volume point growth vs 2010 | 8.0 | % | 10.0 | % | ||
Net sales growth vs 2010 |
11.0 |
% |
13.0 |
% | ||
EPS 1 | $ |
5.00 |
$ |
5.25 |
||
Cap Ex ($ millions) | $ | 80.0 | $ | 90.0 | ||
Effective Tax Rate 1 | 29.0 | % | 30.0 | % | ||
1 FY’10 guidance excludes the impact from the first quarter implementation of highly inflationary accounting in Venezuela and a tax benefit from international income tax audit settlement.
SCHEDULE B: RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
(Unaudited), (Dollars in Thousands, Except Per Share Data)
In addition to its reported results, the Company has included in the tables below adjusted results that the Securities and Exchange Commission defines as “non-GAAP financial measures.” Management believes that such non-GAAP financial measures, when read in conjunction with the Company’s reported results, can provide useful supplemental information for investors analyzing period to period comparisons of the Company’s results.
The following is a reconciliation of net income and diluted earnings per share, presented and reported in accordance with U.S. generally accepted accounting principles, to net income adjusted for certain items:
Herbalife Ltd. | ||||||||||
Supplemental Schedule | ||||||||||
Non-GAAP Financial Measures | ||||||||||
(In thousands, except per share data) | ||||||||||
(Unaudited) | ||||||||||
Quarter Ended 9/30/2010 | ||||||||||
Reported | Adjusting | Adjusted | ||||||||
(GAAP) | Items | (Non-GAAP) | ||||||||
Net Sales | $ | 688,431 | $ | 688,431 | ||||||
Cost of Sales | 133,265 | 133,265 | ||||||||
Gross Profit | 555,166 | 555,166 | ||||||||
Royalty Overrides | 224,061 | 224,061 | ||||||||
SGA | 230,150 | 230,150 | ||||||||
Operating Income | 100,955 | 100,955 | ||||||||
Interest Expense - net | 2,192 | 2,192 | ||||||||
Income before income taxes | 98,763 | 98,763 | ||||||||
Income Taxes | 23,024 | 3,228 | (1 | ) | 26,252 | |||||
Net Income | $ | 75,739 | $ | (3,228 | ) | $ | 72,511 | |||
Diluted EPS | $ | 1.22 | $ | (0.05 | ) | $ | 1.17 | |||
1 Tax benefit from an international income tax audit settlement | ||||||||||
Herbalife Ltd. | |||||||||||
Supplemental Schedule | |||||||||||
Non-GAAP Financial Measures | |||||||||||
(In thousands, except per share data) | |||||||||||
(Unaudited) | |||||||||||
Nine Months Ended 9/30/2010 | |||||||||||
Reported | Adjusting | Adjusted | |||||||||
(GAAP) | Items | (Non-GAAP) | |||||||||
Net Sales | $ | 1,995,870 | $ | 1,995,870 | |||||||
Cost of Sales | 410,298 | $ | (12,715 | ) | (1 | ) | 397,583 | ||||
Gross Profit | 1,585,572 | 12,715 | 1,598,287 | ||||||||
Royalty Overrides | 656,160 | 656,160 | |||||||||
SGA | 648,143 | (11,390 | ) | (2 | ) | 636,753 | |||||
Operating Income | 281,269 | 24,105 | 305,374 | ||||||||
Interest Expense - net | 6,291 | 6,291 | |||||||||
Income before income taxes | 274,978 | 24,105 | 299,083 | ||||||||
Income Taxes | 65,435 | 17,680 | (3 | ) | 83,115 | ||||||
Net Income | $ | 209,543 | $ | 6,425 | $ | 215,968 | |||||
Diluted EPS | $ | 3.37 | $ | 0.10 | $ | 3.47 | |||||
1 Incremental U.S. dollar costs of 2009 imports in Venezuela which were recorded at the unfavorable parallel market exchange rate and were not devalued based on 2010 exchange rates but rather recorded at their historical dollar costs as products were sold | |||||||||||
2 Includes $15,131 foreign exchange loss related to remeasurement of Venezuela's monetary assets and liabilities resulting from adoption of highly inflationary accounting and $3,741 foreign exchange gain resulting from receipt of U.S. dollar approved by CADIVI at the official exchange rate relating to 2009 product importations which were previously registered with CADIVI |
|||||||||||
3 Includes $14,452 favorable income taxes related to Venezuela becoming highly inflationary economy and $3,228 tax benefit from an international income tax audit settlement | |||||||||||
Herbalife Ltd. | |||||||||||
Supplemental Schedule | |||||||||||
Non-GAAP Financial Measures | |||||||||||
(In thousands, except per share data) | |||||||||||
(Unaudited) | |||||||||||
Quarter Ended 9/30/2009 | |||||||||||
Reported | Adjusting | Adjusted | |||||||||
(GAAP) | Items | (Non-GAAP) | |||||||||
Net Sales | $ | 600,218 | $ | 600,218 | |||||||
Cost of Sales | 131,777 | 131,777 | |||||||||
Gross Profit | 468,441 | 468,441 | |||||||||
Royalty Overrides | 194,639 | 194,639 | |||||||||
SGA | 195,968 | $ | (707 | ) | (1 | ) | 195,261 | ||||
Operating Income | 77,834 | 707 | 78,541 | ||||||||
Interest Expense - net | 1,037 | 1,037 | |||||||||
Income before income taxes | 76,797 | 707 | 77,504 | ||||||||
Income Taxes | 18,902 | 4,529 | (2 | ) | 23,431 | ||||||
Net Income | $ | 57,895 | $ | (3,822 | ) | $ | 54,073 | ||||
Diluted EPS | $ | 0.91 | $ | (0.06 | ) | $ | 0.85 | ||||
1 Related to restructuring charge | |||||||||||
2 Includes $4,852 tax benefit from expiration of certain statutes of limitation, tax charge of $537 from an international income tax audit settlement and $214 tax impact of restructuring charges | |||||||||||
Herbalife Ltd. | ||||||||||||
Supplemental Schedule | ||||||||||||
Non-GAAP Financial Measures | ||||||||||||
(In thousands, except per share data) | ||||||||||||
(Unaudited) | ||||||||||||
Nine Months Ended 9/30/2009 | ||||||||||||
Reported | Adjusting | Adjusted | ||||||||||
(GAAP) | Items | (Non-GAAP) | ||||||||||
Net Sales | $ | 1,693,706 | $ | 1,693,706 | ||||||||
Cost of Sales | 356,619 | 356,619 | ||||||||||
Gross Profit | 1,337,087 | 1,337,087 | ||||||||||
Royalty Overrides | 556,921 | 556,921 | ||||||||||
SGA | 568,220 | $ | (2,111 | ) | (1 | ) | 566,109 | |||||
Operating Income | 211,946 | 2,111 | 214,057 | |||||||||
Interest Expense - net | 4,087 | 4,087 | ||||||||||
Income before income taxes | 207,859 | 2,111 | 209,970 | |||||||||
Income Taxes | 60,169 | 4,437 | (2 | ) | 64,606 | |||||||
Net Income | $ | 147,690 | $ | (2,326 | ) | $ | 145,364 | |||||
Diluted EPS | $ | 2.34 | $ | (0.04 | ) | $ | 2.31 | (3 | ) | |||
1 Includes $1,297 restructuring charges and $814 expense from an international income tax audit settlement | ||||||||||||
2 Includes $4,852 tax benefit from expiration of certain statutes of limitation, tax charge of $814 from an international income tax audit settlement and $399 tax impact of restructuring charges | ||||||||||||
3 Amounts may not total due to rounding. | ||||||||||||
9/30/2010 | 12/31/2009 | ||||
Total debt (current and long-term portion) | $ | 209,126 | $ | 250,333 | |
Less: Cash and cash equivalents | 193,490 | 150,801 | |||
Net debt | $ | 15,636 | $ | 99,532 |
CONTACT:
Herbalife Ltd
Media Contact:
Barbara Henderson
SVP,
Worldwide Corp. Comm.
(213) 745-0517
or
Investor Contact:
Amy
Greene
VP, Investor Relations
(213) 745-0474